Fox Run Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Other funds holding VNDA
ACM
Fox Run Management's VNDA Position: Q3 2026 in Review
Fox Run Management opened a new position in Vanda Pharmaceuticals (VNDA) in Q3 2026: 20,875 shares worth $102K. The stake represents 0.01% of the portfolio and ranks #910 among its holdings. This is a return to the name: Fox Run Management previously reported a position in VNDA as recently as Q4 2024.
Fox Run Management first reported a position in VNDA in Q1 2017 and has held it in 8 quarters since. The position peaked at $696K in Q3 2017. 151 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.
- Fox Run Management held 20,875 shares of Vanda Pharmaceuticals worth $102K as of Q3 2026.
- Vanda Pharmaceuticals was a new Fox Run Management position in Q3 2026.
- Vanda Pharmaceuticals made up 0.01% of Fox Run Management's portfolio in Q3 2026, its #910 holding.
- Fox Run Management first reported a position in Vanda Pharmaceuticals in Q1 2017 and has held it in 8 quarters since.
- Fox Run Management's Vanda Pharmaceuticals position peaked at $696K in Q3 2017.
- 151 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.
Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.